On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
TuesdayNov 29, 2022 1:30 pm

Prime Harvest Inc. Positioned to Lead California’s Cannabis Market with Direct-to-Consumer Expansion

Prime Harvest is the parent company of Jaxx Cannabis, its D2C operations actively expanding throughout California Prime Harvest’s brand partners strongly positioned across multiple segments of the cannabis value chain Brand partners include Mary's Medicinals, STIIIZY, Lime Cannabis, and Tonik Revenue diversification is critical to sustainable growth in the cannabis industry, and it’s central to the strategy of Prime Harvest, a technology-focused, full-service cannabis corporation. With a strong portfolio of successful brand partners, Prime Harvest is strongly positioned to lead California’s sector through robust diversification across multiple segments of the cannabis value chain. “Our approach is to create strong alliances…

Continue Reading

TuesdayNov 29, 2022 12:45 pm

Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) Carries Out Exploratory Drilling Work at Iska Iska Project; Receives Mention by Brent Cook as Showing ‘Great Potential’

Bolivia’s Potosi region has long been one of the world’s most prolific silver deposits, with continuous mining operations taking place over the past 500 years Eloro Resources possesses a 99% option agreement on the Iska Iska deposit, a major polymetallic epithermal porphyry complex covering over 900 hectares of land Eloro Resources was recently highlighted by renowned mining analyst, Brent Cook during his appearance on the Wall Street Silver podcast Eloro’s Iska Iska project was characterized as a polymetallic mining project possessing great potential due to its size as well as the mining team’s technical nous The discovery of Bolivia’s Potosi…

Continue Reading

TuesdayNov 29, 2022 12:00 pm

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Pipeline Focused on Creating Innovative Immunotherapeutic Products for Treating Underserved Infectious and Autoimmune Diseases

In collaboration with Max Planck Institute for Multidisciplinary Sciences (“MPI”) and the University Medical Center Göttingen, BiondVax is developing a pipeline of NanoAb therapies The company’s co-lead scientific research collaborator, Professor Dr. Dirk Görlich, director at MPI, was awarded the inaugural $1.4 million World Laureates Association (“WLA”) Prize in Life Sciences or Medicine for his work describing protein transport within the cell The global market for autoimmune disorder therapies is expected to reach $90.7 billion by 2024; The global market for infectious disease therapeutics is expected to reach $167 billion by 2030 BiondVax Pharmaceuticals (NASDAQ: BVXV) is a biotechnology company…

Continue Reading

TuesdayNov 29, 2022 11:15 am

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) Leads the Way Towards a Renewable Energy-Powered Future Within Canada

The recent UN-sponsored COP27 Conference has highlighted the pressing need for significant climate-focused initiatives A UN panel led by Canada’s former environment minister has pushed for an urgent shift away from fossil fuels and towards renewable energy sources RNG platform operator, EverGen Infrastructure have been at the forefront of the renewable energy transformation taking place across both, the province of British Columbia and Canada as a whole The company has recently stated its goal to expand its production capacity to 20 locations across the country by 2025 The United Nations Framework Convention on Climate Change – better known as COP27…

Continue Reading

TuesdayNov 29, 2022 10:30 am

Odyssey Health, Inc. (ODYY) Development of Neuropharmaceuticals for TBIs and CNS Maladies, Portends Competitiveness in Area of Unmet Medical Needs

A growing chorus of concerns about brain concussions resulting from athletic events is helping to propel new interest in developing pharmaceuticals to treat this “unmet medical need” Concussion treatments have largely focused on simple rest, but medical product developer Odyssey Health Inc. is developing a potential treatment to reduce brain inflammation so needed therapy can get to the site of a brain injury Odyssey is also developing solutions for other central nervous system troubles, such as the highly fatal childhood disease Niemann-Pick type C, and nerve gas exposure sickness The neuropharmaceutical market is forecast to have a great deal of…

Continue Reading

TuesdayNov 29, 2022 9:45 am

Reklaim Ltd. (TSX.V: MYID) (OTCQB: MYIDF) Positioned to Fill Data Void as Governments and Tech Companies Phase Out Third-Party Cookies

Governments are taking action to regulate, limit, or eliminate the use of third-party cookies that collect user information The European Union ePrivacy Directive requires parties to obtain user consent before sending cookies Google intends to phase out support for third-party cookies from its Chrome browser in 2024 Reklaim’s fully consensual, consumer-verified data ecosystem offers a high-quality, fully compliant solution to advertisers and data companies while rewarding users for providing access to data The online advertising industry is transforming rapidly as governments take action to regulate, limit, or eliminate the use of third-party cookies. As a result, Reklaim (TSX.V: MYID) (OTCQB:…

Continue Reading

TuesdayNov 29, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Investigation of DehydraTECH-CBD’s Potential Therapeutic Value for Diabetes and Defmentia with New Studies

Lexaria’s Patented DehydraTECH technology improves the bioavailability of pharmaceuticals and therapeutics for a number of developing applications Lexaria is set to complete its DEM-A22-1 and DIAB-A22-1 studies on dementia and diabetes, respectively, in January 2023, with analysis and reporting set to follow soon after These studies will build on the just-concluded hypertension clinical study whose results were “truly exceptional,” demonstrating a statistically significant lowering of blood pressure in the patient population over multiple weeks There is an established link between hypertension and vascular dementia, along with hypertension being twice as frequent in people with diabetes and hypertensive patients being at…

Continue Reading

MondayNov 28, 2022 2:15 pm

IRA Catalyzes Solar Stocks as GeoSolar Technologies Inc. Eyes Public Listing

The Inflation Reduction Act (“IRA”), a linchpin to the U.S. meeting its emissions goals, includes $369 billion dedicated to expanding renewable energy The new bill is projected to generate $600 billion in capital investment, 550,000 clean energy jobs, and 525-550 gigawatts of new clean power The passage of the IRA served as a catalyst to solar stocks and continues to grow interest in upstarts like GeoSolar Technologies President Joe Biden is on a mission to cement his legacy as an ambassador of all things anti-climate change. The passage of the Inflation Reduction Act will forever be his key piece of…

Continue Reading

MondayNov 28, 2022 1:30 pm

Correlate Infrastructure Partners Inc. (CIPI) Helps Clients Achieve ESG Goals Through Proprietary Analytics, Advisement

Corporations worldwide are working to improve their climate friendliness through a variety of environmental, social and governance (“ESG”) factors U.S. distributed energy solutions innovator Correlate Infrastructure Partners Inc. is a company working strategically with clients to assess their energy emissions profile and identify possible improvements and funding opportunities for those improvements CIPI’s advisement helps clients achieve transparency in their ESG responsibility and to make improvements in a cost-beneficial manner CIPI has realized record revenues during the most recent quarter as a result of its operations and still has $16.2 million in unrecognized revenues anticipated from work currently under way Environmental,…

Continue Reading

MondayNov 28, 2022 12:45 pm

RHK 2022 Disruptive Growth Conference to Introduce Disruptive Growth Companies to New Investors

RHK Capital is organizing the RHK Capital 2022 Disruptive Growth Conference, at the offices of Reed Smith, NYC. Spread over two days on December 5-6, 2022, investors, brokers, wealth managers, capitalists, growth companies and enterprises, are invited to attend this interactive learning and network-building conference in person or via webcast. The focus of RHK Capital in this in person and webcast conference is to spotlight aspiring companies and young industries with disruptive growth potential.  The RHK Capital 2022 Disruptive Growth Conference is attended by over 200 institutional investors, accredited investors, family offices, Wall Street analysts, financial advisors, broker-dealer wealth managers,…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.


Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered